Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Post by TenFingerson Jun 05, 2018 8:53am
93 Views
Post# 28124711

Pet Trials

Pet TrialsPet treatment is actually a massively underestimated market, IMO.

People medicate their pets for everything - from anxiety to digestive disorders to chronic pain, etc... Many people treat their dogs better than human children.

Cannabis has been suspected for a long time to be a great candidate for treatment of canines, but little has been understood about it, and many trials and data were very bad - I read a study recently done in Colorado where treated canines died when fed human strength edibles for medical treatment. This is because canines are now known to have several magnitudes more cannabinoid receptors than humans (think taking like a 100X dose of your favorite edible - yes, you could die).

So, we are at a point where we need much much much more data - how much is a good dose? What is a good delivery mechanism? How often should we treat for various ailments? CBD versus THC levels? What about different breeds, is there a correlation to receptors? What about cats?

I think there are many patents, treatment methods and formulae to be developed. They are on the right track here - carefully moving forward with trials. A trial iplies THAT THEY ARE TESTING SOMETHING - they must have a formula, a product, something, otherwise, what are they trialing? The right breakthrough could lead to a trusted, medical study-backed branding of pet products with proprietary formulas - now, think manufacturing and distribution at NR to get those products made and distributed all over the world. :)
<< Previous
Bullboard Posts
Next >>